The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level
Open Access
- 29 April 2005
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 3 (5), 1102-1103
- https://doi.org/10.1111/j.1538-7836.2005.01312.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular riskThe Lancet, 2003
- Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosisBritish Journal of Haematology, 2002
- The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structureBlood, 2000
- Prothrombin G20210A, Factor V Leiden, and Factor XIII Val34Leu: Common Mutations of Blood Coagulation Factors and Deep Vein Thrombosis in AustriaThrombosis Research, 2000
- Examining Thrombin Hydrolysis of the Factor XIII Activation Peptide Segment Leads to a Proposal for Explaining the Cardioprotective Effects Observed with the Factor XIII V34L MutationJournal of Biological Chemistry, 2000
- Factor XIII Val34Leu Polymorphism and Risk of Deep Vein ThrombosisThrombosis and Haemostasis, 2000
- Association of a Common Polymorphism in the Factor XIII Gene With Venous ThrombosisBlood, 1999
- Factor XIII Val34Leu Is a Genetic Factor Involved in the Aetiology of Venous ThrombosisThrombosis and Haemostasis, 1999
- Effect of fibrin structure on plasmin-mediated dissolution of plasma clotsBlood Coagulation & Fibrinolysis, 1995
- Primer-directed enzymatic amplification of DNA with a thermostable DNA polymeraseScience, 1988